This site is intended for healthcare professionals only

In association with the Cardiorenal Forum


  • Salt reduction in hypertension – does it make a difference?

  • Dietary sodium and blood pressure in treatment-resistant hypertension

  • Chronic kidney disease markers as independent risk factors for incident atrial fibrillation

  • Uromodulin and risk for kidney failure

  • Heart monitor screen

    Pharmacotherapy for weight management in HFpEF: Do we have to lose big to win small?

  • Overweight man measuring waist

    Improving outcomes for patients with HFpEF and obesity: The STEP-HFpEF trial

  • Man taking pill with water

    Dapagliflozin and cardiovascular risks with worsening renal function

  • Rack of blood sample tubes

    Cardiorenal biomarkers in the CREDENCE trial

  • Inhibition of the renin–angiotensin–aldosterone system in early chronic kidney disease: do we know as much as we think we do?


For the latest news and articles
Sign up to Renal Review newsletters